Bilsel S, San T, Erşahin C, Moini H, Okar I, Emerk K
Department of Biochemistry, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Thromb Res. 1994 Dec 1;76(5):433-40. doi: 10.1016/0049-3848(95)90175-f.
Defibrotide is an antithrombotic and profibrinolytic drug which modulates endothelial function. The drug increases prostacyclin and tissue plasminogen activator while it decreases plasminogen activator inhibitor synthesis by endothelial cells. In this study, in vivo effects of defibrotide on the morphology of endothelial cells and vessel wall of the healthy rabbits were investigated by light and electron microscopy. The examination of the carotid arteries of healthy rabbits after infusion of saline or defibrotide (10 mg/kg/hr) in saline solution for three hours revealed that the drug had induced dramatic morphological changes in all the test animals while no change was observed in control group. The changes observed after defibrotide administration, such as the decrease in hill and valley-like appearance of endothelial surface, and thinning of the intimal layer provides evidence for the vasorelaxant effect of the drug, while the decrease in the number of blood cells adhering to the endothelial surface confirms the antithrombotic effect of defibrotide. Finally the decrease in the number of crater-like structures may be due to the cytoprotective effect of the drug.
去纤苷是一种调节内皮功能的抗血栓形成和促纤溶药物。该药物可增加前列环素和组织纤溶酶原激活物,同时减少内皮细胞合成纤溶酶原激活物抑制剂。在本研究中,通过光学显微镜和电子显微镜研究了去纤苷对健康兔内皮细胞形态和血管壁的体内作用。对健康兔颈动脉输注生理盐水或含去纤苷(10 mg/kg/小时)的生理盐水溶液3小时后进行检查发现,该药物在所有试验动物中均引起了显著的形态学变化,而对照组未观察到变化。去纤苷给药后观察到的变化,如内皮表面峰谷样外观减少和内膜层变薄,为该药物的血管舒张作用提供了证据,而粘附在内皮表面的血细胞数量减少证实了去纤苷的抗血栓形成作用。最后,火山口样结构数量的减少可能归因于该药物的细胞保护作用。